The FY23 PCRP Idea Development Award is intended to support new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP Mission. The key components of this award mechanism are:
• Innovation: Research deemed innovative may represent a new paradigm, challenge current paradigms, look at existing problems from new perspectives, leverage unique study populations, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative. Projects involving multidisciplinary and/or data science approaches are especially encouraged.
• Impact: Applications are required to address and provide a solution to one or more of the FY23 PCRP Overarching Challenges. The potential impact of the research, both short-term and long-term, in addressing the FY23 PCRP Overarching Challenge(s) should be clearly described. High-impact research will, if successful, significantly advance prostate cancer research and/or patient care.
• Preliminary Data: Due to this award’s emphasis on innovation, the presentation of preliminary data relevant to prostate cancer and the proposed project is encouraged, but not required. Any unpublished, preliminary data provided should originate from the laboratory of the Principal Investigator (PI) or a member(s) of the research team. Regardless of whether preliminary data are included, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature.
Deadlines:
• Required Pre-Application Deadline: June 29, 2023
• Application Submission Deadline: July 20, 2023
The Mission of the FY23 PCRP is to fund research that will eliminate death and suffering from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease. Within this context, the PCRP is interested in supporting research that addresses specific gaps in prostate cancer research and clinical care; therefore, applications are required to address one or more of the following FY23 PCRP Overarching Challenges:
• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer
• Develop new treatments or improve upon existing therapies to improve outcomes for men with lethal prostate cancer
• Advance health equity and reduce disparities in prostate cancer
• Define the biology of prostate cancer progression to lethal prostate cancer to reduce death
Each investigator may be named on only one FY23 PCRP Idea Development Award application as a PI.
Although a PI may be eligible for both the Established Investigator and New Investigator categories, only one category may be chosen; the choice of application category is at the PI’s discretion.
New Investigator: By the application submission deadline date, the PI must: ○ Have the freedom to pursue independent research goals without formal mentorship; ○ Have not previously received a PCRP Idea Development Award and/or Health Disparity Research Award; and ○ Be an independent, early-career investigator within 10 years after completion of his/her terminal degree by the time of the application submission deadline (excluding time spent in residency or on family medical leave). Time spent as a postdoctoral fellow is not excluded. Lapses in research time or appointments as denoted in the biographical sketch may be articulated in the application. ○ New Investigators working within a laboratory team are eligible to apply for this award provided they can demonstrate that they have the freedom to pursue independent research goals without formal mentorship. Graduate students and junior postdoctoral fellows with less than 3 years postdoctoral training by the application submission deadline are not eligible for this award
Established Investigator ○ Independent investigators at all levels are eligible.
The anticipated direct costs budgeted for the entire period of performance for an FY23 PCRP Award should not exceed $900,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
